These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29509268)

  • 41. Pravastatin improves atherosclerosis in mice with hyperlipidemia by inhibiting TREM-1/DAP12.
    Wang HM; Gao JH; Lu JL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4995-5003. PubMed ID: 30070336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression.
    Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F
    Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.
    Härdtner C; Kornemann J; Krebs K; Ehlert CA; Jander A; Zou J; Starz C; Rauterberg S; Sharipova D; Dufner B; Hoppe N; Dederichs TS; Willecke F; Stachon P; Heidt T; Wolf D; von Zur Mühlen C; Madl J; Kohl P; Kaeser R; Boettler T; Pieterman EJ; Princen HMG; Ho-Tin-Noé B; Swirski FK; Robbins CS; Bode C; Zirlik A; Hilgendorf I
    Basic Res Cardiol; 2020 Dec; 115(6):78. PubMed ID: 33296022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guanxin Xiaoban capsules could treat atherosclerosis by affecting the gut microbiome and inhibiting the AGE-RAGE signalling pathway.
    Dongliang Y; Yang R; Peng S; Deng J; Huo Y; Deng Z; Yau Y; Liu J; Liao D; Cheng C
    J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35580023
    [No Abstract]   [Full Text] [Related]  

  • 46. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
    Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-21-3p regulates AGE/RAGE signalling and improves diabetic atherosclerosis.
    Shao M; Yu M; Zhao J; Mei J; Pan Y; Zhang J; Wu H; Yu M; Liu F; Chen G
    Cell Biochem Funct; 2020 Oct; 38(7):965-975. PubMed ID: 32196704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice.
    Zhao D; Tong L; Zhang L; Li H; Wan Y; Zhang T
    Mol Med Rep; 2016 Dec; 14(6):4983-4990. PubMed ID: 27840935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study.
    Fukushima Y; Daida H; Morimoto T; Kasai T; Miyauchi K; Yamagishi S; Takeuchi M; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M;
    Cardiovasc Diabetol; 2013 Jan; 12():5. PubMed ID: 23289728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition.
    Janssen H; Wagner CS; Demmer P; Callies S; Sölter G; Loghmani-khouzani H; Hu N; Schuett H; Tietge UJ; Warnecke G; Larmann J; Theilmeier G
    Dis Model Mech; 2015 Sep; 8(9):1071-80. PubMed ID: 26092124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.
    Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG
    Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. All-trans retinoic acid effectively reduces atheroma plaque size in a rabbit model of high-fat-induced atherosclerosis.
    Zarei L; Bahrami M; Farhad N; Froushani SMA; Abbasi A
    Adv Clin Exp Med; 2018 Dec; 27(12):1631-1636. PubMed ID: 30048051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.
    Bot I; Jukema JW; Lankhuizen IM; van Berkel TJ; Biessen EA
    Atherosclerosis; 2011 Feb; 214(2):295-300. PubMed ID: 21130458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo fluorescence-mediated tomography imaging demonstrates atorvastatin-mediated reduction of lesion macrophages in ApoE-/- mice.
    Larmann J; Frenzel T; Schmitz M; Hahnenkamp A; Demmer P; Immenschuh S; Tietge UJ; Bremer C; Theilmeier G
    Anesthesiology; 2013 Jul; 119(1):129-41. PubMed ID: 23559030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advanced glycation end products impair the functions of saphenous vein but not thoracic artery smooth muscle cells through RAGE/MAPK signalling pathway in diabetes.
    Sun Y; Kang L; Li J; Liu H; Wang Y; Wang C; Zou Y
    J Cell Mol Med; 2016 Oct; 20(10):1945-55. PubMed ID: 27297874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
    Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
    Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atorvastatin attenuates atherosclerotic plaque destabilization by inhibiting endoplasmic reticulum stress in hyperhomocysteinemic mice.
    Jia F; Wu C; Chen Z; Lu G; Sun J
    Mol Med Rep; 2016 Apr; 13(4):3574-80. PubMed ID: 26956896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis.
    Grothusen C; Bley S; Selle T; Luchtefeld M; Grote K; Tietge UJ; Drexler H; Schieffer B
    Atherosclerosis; 2005 Sep; 182(1):57-69. PubMed ID: 16115475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.